Cito Capital Group, LLC Charles River Laboratories International, Inc. Transaction History
Cito Capital Group, LLC
- $258 Million
- Q2 2024
A detailed history of Cito Capital Group, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cito Capital Group, LLC holds 1,150 shares of CRL stock, worth $216,982. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,150
Previous 1,150
-0.0%
Holding current value
$216,982
Previous $312,000
23.72%
% of portfolio
0.09%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding CRL
# of Institutions
714Shares Held
51.7MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$960 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$394 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$360 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$332 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.6B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...